Reporting Segment and Geographic Information (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

Schedule Of Revenue By Region And Customer Type And Commercial Revenue By Product

Revenue by region for the three-months ended March 31, 2026 and 2025 were as follows (in thousands):


	Three-Months Ended
	March 31, 2026			March 31, 2025
Revenue by region:
United States	$	18,570		$	17,756
Japan		439			634
European Union		-			49
Australia		40			40
United Kingdom		202			35
Total	$	19,251		$	18,514

Revenue by customer type for the three-months ended March 31, 2026 and 2025 were as follows (in thousands):


	Three-Months Ended
	March 31, 2026			March 31, 2025
Revenue by customer type:
Commercial sales	$	19,243		$	18,450
Deferred commercial revenue recognized		8			8
BARDA revenue for right of first access		-			56
Total	$	19,251		$	18,514

Commercial revenue by product for the three-months ended March 31, 2026 and 2025 were as follows (in thousands):


	Three-Months Ended
	March 31, 2026			March 31, 2025
Commercial revenue by product:
RECELL	$	17,121		$	17,675
Other wound care products		1,935			586
Lease revenue		187			189
Total commercial sales	$	19,243		$	18,450

Summary of Consolidated Net Loss by Segment

Consolidated net loss by segment for the three-months ended March 31, 2026 and 2025 were as follows (in thousands):


		Three-Months Ended
		March 31, 2026			March 31, 2025
Total revenues		$	19,251		$	18,514
Purchases of inventory			(2,778	)		(2,497	)
Other cost of sales			(745	)		(336	)
Gross profit			15,728			15,681
Operating expenses:
Sales and marketing			(12,841	)		(14,834	)
General and administrative			(6,061	)		(6,390	)
Research and development			(5,629	)		(6,284	)
Total operating expenses			(24,531	)		(27,508	)
Operating loss			(8,803	)		(11,827	)
Interest expense			(1,424	)		(1,233	)
Other expense, net			(395	)		(791	)
Loss before income taxes			(10,622	)		(13,851	)
Income tax benefit (expense)			11			(8	)
Net loss		$	(10,611	)	$	(13,859	)